R. Rapoza

发表

Postadsorptive transitions in fibrinogen: influence of polymer properties.

T. Horbett, R. Rapoza, 1990, Journal of biomedical materials research.

Serial analysis of the malapposed and uncovered struts of the new generation of everolimus-eluting bioresorbable scaffold with optical coherence tomography.

Patrick W Serruys, Yoshinobu Onuma, Richard Rapoza, 2011, JACC. Cardiovascular interventions.

Design Effect of Metallic (Durable) and Polymeric (Resorbable) Stents on Blood Flow and Platelet Activation

M. Slepian, R. Rapoza, D. Bluestein, 2018, Artificial organs.

Setting acceptance criteria for validation of analytical methods of drug eluting stents: Minimum requirements for analytical variability.

R. Rapoza, M. Kamberi, H. Garcia, 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Design Principles of Bioresorbable Polymeric Scaffolds.

Richard Rapoza, Mary Beth Kossuth, R. Rapoza, 2016, Interventional cardiology clinics.

TCT-614 Detailed Morphologic Characterization of the Strut Composition Following Absorb Scaffold Placement in a Porcine Coronary Artery Model Through 48 Months

R. Virmani, F. Otsuka, F. Kolodgie, 2014 .

Vasomotor Function Comparative Assessment at 1 and 2 Years Following Implantation of the Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold and the Xience V Everolimus-Eluting Metallic Stent in Porcine Coronary Arteries: Insights From In Vivo Angiography, Ex Vivo Assessment, and Gene Analysis

A. Quyyumi, D. Giddens, B. Gogas, 2016, JACC. Cardiovascular interventions.

Changes in the SDS elutability of fibrinogen adsorbed from plasma to polymers.

T. Horbett, R. Rapoza, 1989, Journal of biomaterials science. Polymer edition.

The effects of concentration and adsorption time on the elutability of adsorbed proteins in surfactant solutions of varying structures and concentrations

T. Horbett, R. Rapoza, 1990 .

Bioresorbable Everolimus-Eluting Vascular Scaffold for Patients With Peripheral Artery Disease (ESPRIT I): 2-Year Clinical and Imaging Results.

F. Vermassen, D. Scheinert, A. Schmidt, 2016, JACC. Cardiovascular interventions.

Randomized Comparison Between Everolimus-Eluting Bioresorbable Scaffold and Metallic Stent: Multimodality Imaging Through 3 Years.

P. Fitzgerald, P. Serruys, G. Stone, 2020, JACC. Cardiovascular interventions.

Flare spots in intravascular optical coherence tomography images of bioabsorbable stents.

T. Milner, M. Feldman, J. Dijkstra, 2014, JACC. Cardiovascular imaging.

Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Ev

R. Whitbourn, P. Serruys, S. Windecker, 2014, JACC. Cardiovascular interventions.

Effect of the endothelial shear stress patterns on neointimal proliferation following drug-eluting bioresorbable vascular scaffold implantation: an optical coherence tomography study.

Michail I. Papafaklis, Fanis G. Kalatzis, D. Fotiadis, 2014, JACC. Cardiovascular interventions.

Comparison of angiographic and intravascular ultrasound vessel measurements in infra-popliteal endovascular interventions: The below-the-knee calibration study.

S. Parikh, B. Derubertis, H. Garcia-Garcia, 2021, Cardiovascular revascularization medicine : including molecular interventions.

Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial.

Hiroki Shiomi, Satoshi Yasuda, Yoshinobu Onuma, 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Bioresorbable vascular scaffold treatment induces the formation of neointimal cap that seals the underlying plaque without compromising the luminal dimensions: a concept based on serial optical coherence tomography data.

R. Whitbourn, P. Serruys, S. Windecker, 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Vascular response of the segments adjacent to the proximal and distal edges of the ABSORB everolimus-eluting bioresorbable vascular scaffold: 6-month and 1-year follow-up assessment: a virtual histology intravascular ultrasound study from the first-in-man ABSORB cohort B trial.

R. Whitbourn, P. Serruys, H. Garcia-Garcia, 2012, JACC. Cardiovascular interventions.

Angiographic geometric changes of the lumen arterial wall after bioresorbable vascular scaffolds and metallic platform stents at 1-year follow-up.

Bernard Chevalier, Patrick W Serruys, Richard Rapoza, 2011, JACC. Cardiovascular interventions.

Circumferential distribution of the neointima at six-month and two-year follow-up after a bioresorbable vascular scaffold implantation: a substudy of the ABSORB Cohort B Clinical Trial.

R. Whitbourn, P. Serruys, S. Windecker, 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Very late vasomotor responses and gene expression with bioresorbable scaffolds and metallic drug‐eluting stents

G. Stone, D. Giddens, H. Jo, 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Three-year results of clinical follow-up after a bioresorbable everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB trial.

P. Serruys, D. Dudek, E. Regar, 2010, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Lessons Learned Regarding Handling and Deployment of the Absorb Bioresorbable Vascular Scaffold in Infrapopliteal Arteries

R. Rapoza, R. Varcoe, Shannon D. Thomas, 2017, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

INTRACORONARY OPTICAL COHERENCE TOMOGRAPHY (OCT) AND HISTOLOGY 2, 3 AND 4 YEARS AFTER IMPLANTATION OF BIORESORBABLE EVEROLIMUS-ELUTING STENTS IN A PORCINE CORONARY MODEL: AN ATTEMPT TO DECIPHER THE HUMAN OCT IMAGES IN THE ABSORB TRIAL

R. Virmani, E. Regar, Y. Onuma, 2010 .

Serial in vivo intravascular ultrasound-based echogenicity changes of everolimus-eluting bioresorbable vascular scaffold during the first 12 months after implantation insights from the ABSORB B trial.

R. Whitbourn, P. Serruys, S. Windecker, 2011, JACC. Cardiovascular interventions.

Dynamics of vessel wall changes following the implantation of the absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months.

R. Whitbourn, P. Serruys, S. Windecker, 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Relation Between Bioresorbable Scaffold Sizing Using QCA-Dmax and Clinical Outcomes at 1 Year in 1,232 Patients From 3 Study Cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II).

R. Whitbourn, P. Serruys, H. Garcia-Garcia, 2015, JACC. Cardiovascular interventions.

Very Late Restenosis Following Bioresorbable Scaffold Implantation.

S. Saito, K. Tanabe, Takeshi Kimura, 2017, JACC. Cardiovascular interventions.

Cardiac Steatosis and Left Ventricular Dysfunction in HIV-Infected Patients Treated With Highly Active Antiretroviral Therapy

T. Milner, M. Feldman, J. Dijkstra, 2014 .

Plasma deposition of ultrathin films of poly(2−hydroxyethyl methacrylate) : surface analysis and protein adsorption measurements

G. López, B. Ratner, T. Horbett, 1993 .

Paving the way to a bioresorbable technology: Development of the absorb BRS program

R. Rapoza, J. Fox, L. Perkins, 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds.

Patrick W Serruys, Yoshinobu Onuma, Richard Rapoza, 2011, European heart journal.

Evaluation of the Second Generation of a Bioresorbable Everolimus Drug-Eluting Vascular Scaffold for Treatment of De Novo Coronary Artery Stenosis: Six-Month Clinical and Imaging Outcomes

Bernard Chevalier, Patrick W Serruys, Yoshinobu Onuma, 2010, Circulation.

In vivo evaluation of stent strut distribution patterns in the bioabsorbable everolimus-eluting device: An OCT ad hoc analysis of the revision 1.0 and revision 1.1 stent design in the ABSORB clinical trial

Yoshinobu Onuma, Richard Rapoza, Evelyn Regar, 2010 .

Temporal evolution of strut light intensity after implantation of bioresorbable polymeric intracoronary scaffolds in the ABSORB cohort B trial-an application of a new quantitative method based on optical coherence tomography.

J. Reiber, P. Serruys, H. Garcia-Garcia, 2014, Circulation journal : official journal of the Japanese Circulation Society.

In vivo characterisation of bioresorbable vascular scaffold strut interfaces using optical coherence tomography with Gaussian line spread function analysis.

Patrick W Serruys, Yoshinobu Onuma, Alexander Sheehy, 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Evaluation with in vivo optical coherence tomography and histology of the vascular effects of the everolimus-eluting bioresorbable vascular scaffold at two years following implantation in a healthy porcine coronary artery model: implications of pilot results for future pre-clinical studies

R. Virmani, P. Serruys, H. Garcia-Garcia, 2011, The International Journal of Cardiovascular Imaging.

Long-Term Safety of an Everolimus-Eluting Bioresorbable Vascular Scaffold and the Cobalt-Chromium XIENCE V Stent in a Porcine Coronary Artery Model

R. Virmani, F. Otsuka, F. Kolodgie, 2014, Circulation. Cardiovascular interventions.

Stability testing of drug eluting stents

Marika Kamberi, Richard Rapoza, R. Rapoza, 2016 .

Vascular healing and integration of a fully bioresorbable everolimus-eluting scaffold in a rabbit iliac arterial model.

R. Virmani, F. Otsuka, M. Nakano, 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

First Serial Assessment at 6 Months and 2 Years of the Second Generation of Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold: A Multi-Imaging Modality Study

Bernard Chevalier, Yoshinobu Onuma, Richard Rapoza, 2012, Circulation. Cardiovascular interventions.

Evaluation of chemical stability of polymers of XIENCE everolimus-eluting coronary stents in vivo by pyrolysis-gas chromatography/mass spectrometry.

R. Virmani, F. Kolodgie, R. Rapoza, 2018, Journal of biomedical materials research. Part B, Applied biomaterials.

Intracoronary optical coherence tomography and histology of overlapping everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: the potential implications for clinical practice.

R. Virmani, P. Serruys, L. Räber, 2013, JACC. Cardiovascular interventions.

Design principles and performance of bioresorbable polymeric vascular scaffolds.

R. Rapoza, S. Hossainy, J. Oberhauser, 2009, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Lumen gain and restoration of pulsatility after implantation of a bioresorbable vascular scaffold in porcine coronary arteries.

R. Virmani, R. Rapoza, L. Perkins, 2014, JACC. Cardiovascular interventions.

ABSORB II randomized controlled trial: a clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease c

P. Serruys, H. Garcia-Garcia, B. Chevalier, 2012, American heart journal.

Glow discharge plasma deposition of tetraethylene glycol dimethyl ether for fouling-resistant biomaterial surfaces.

B D Ratner, G. López, B. Ratner, 1992, Journal of biomedical materials research.

Head to head comparison of optical coherence tomography, intravascular ultrasound echogenicity and virtual histology for the detection of changes in polymeric struts over time: insights from the ABSORB trial.

R. Whitbourn, P. Serruys, S. Windecker, 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Endothelial-dependent vasomotion in a coronary segment treated by ABSORB everolimus-eluting bioresorbable vascular scaffold system is related to plaque composition at the time of bioresorption of the polymer: indirect finding of vascular reparative therapy?

Patrick W Serruys, Yoshinobu Onuma, Richard Rapoza, 2012, European heart journal.

Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography.

R. Whitbourn, P. Serruys, S. Windecker, 2011, JACC. Cardiovascular interventions.

Impact of Coronary Atherosclerosis on Bioresorbable Vascular Scaffold Resorption and Vessel Wall Integration

R. Virmani, A. Finn, J. Granada, 2020, JACC. Basic to translational science.

Technology limitations of BRS in bifurcations.

P. Serruys, R. Rapoza, S. Hossainy, 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Optical coherence tomography (OCT) of overlapping bioresorbable scaffolds: from benchwork to clinical application.

R. Virmani, P. Serruys, S. Windecker, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Comparison between the first and second generation bioresorbable vascular scaffolds: a six month virtual histology study.

R. Whitbourn, P. Serruys, S. Garg, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

TCT-33 Intracoronary Optical Coherence Tomography and Histology of Overlapping Everolimus-Eluting Bioresorbable Vascular Scaffolds in a Porcine Coronary Artery Model: The Potential Implications for Clinical Practice

R. Virmani, P. Serruys, L. Räber, 2012 .

Echogenicity as a surrogate for bioresorbable everolimus-eluting scaffold degradation: analysis at 1-, 3-, 6-, 12- 18, 24-, 30-, 36- and 42-month follow-up in a porcine model

J. Reiber, P. Serruys, H. Garcia-Garcia, 2015, The International Journal of Cardiovascular Imaging.

Vascular compliance changes of the coronary vessel wall after bioresorbable vascular scaffold implantation in the treated and adjacent segments.

Patrick W Serruys, Yoshinobu Onuma, Richard Rapoza, 2012, Circulation journal : official journal of the Japanese Circulation Society.

In vivo evaluation of stent strut distribution patterns in the bioabsorbable everolimus-eluting device: an OCT ad hoc analysis of the revision 1.0 and revision 1.1 stent design in the ABSORB clinical trial.

Patrick W Serruys, Yoshinobu Onuma, Evelyn Regar, 2010, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Bioresorption and Vessel Wall Integration of a Fully Bioresorbable Polymeric Everolimus-Eluting Scaffold: Optical Coherence Tomography, Intravascular Ultrasound, and Histological Study in a Porcine Model With 4-Year Follow-Up.

R. Virmani, P. Serruys, Shimpei Nakatani, 2016, JACC. Cardiovascular interventions.

Business Perspective: Case Study: Commercialized Cell-Free Cardiovascular Implant

Richard Rapoza, Alexander Sheehy, Byron J. Lambert, 2016 .

Circumferential evaluation of the neointima by optical coherence tomography after ABSORB bioresorbable vascular scaffold implantation: can the scaffold cap the plaque?

Bernard Chevalier, Patrick W Serruys, Richard Rapoza, 2012, Atherosclerosis.

In vivo visualisation by three-dimensional optical coherence tomography of stress crazing of a bioresorbable vascular scaffold implanted for treatment of human coronary stenosis.

P. Serruys, Y. Onuma, R. Diletti, 2012, EuroIntervention.

Angiographic maximal luminal diameter and appropriate deployment of the everolimus-eluting bioresorbable vascular scaffold as assessed by optical coherence tomography: an ABSORB cohort B trial sub-study.

Patrick W Serruys, Yoshinobu Onuma, Richard Rapoza, 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Biomolecules and surfaces

Buddy D. Ratner, David G. Castner, Thomas A. Horbett, 1990 .

Analysis of 1 year virtual histology changes in coronary plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffold

R. Whitbourn, P. Serruys, S. Windecker, 2011, The International Journal of Cardiovascular Imaging.

Improving efficiency and operator proficiency during percutaneous coronary interventions utilizing a standardized optical coherence tomography workflow

E. Secemsky, R. Rapoza, A. Darki, 2022, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Safety and efficiency of percutaneous coronary intervention using a standardised optical coherence tomography workflow.

R. Rapoza, D. Spoon, E. Korngold, 2022, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Spatial distribution and temporal evolution of scattering centers by optical coherence tomography in the poly(L-lactide) backbone of a bioresorbable vascular scaffold.

Patrick W Serruys, Yoshinobu Onuma, Alexander Sheehy, 2012, Circulation journal : official journal of the Japanese Circulation Society.

Evaluation of the Second Generation of a Bioresorbable Everolimus Drug-Eluting Vascular Scaffold for Treatment of De Novo Coronary Artery Stenosis Six-Month Clinical and Imaging Outcomes

R. Whitbourn, P. Serruys, S. Windecker, 2010 .

Evaluation of the Second Generation of a Bioresorbable Everolimus Drug-Eluting Vascular Scaffold for Treatment of De Novo Coronary Artery StenosisClinical Perspective

R. Whitbourn, P. Serruys, S. Windecker, 2010 .

Evaluation of the Second Generation of a Bioresorbable Everolimus Drug-Eluting Vascular Scaffold for Treatment of De Novo Coronary Artery Stenosis: Six-Month Clinical and Imaging Outcomes

R. Whitbourn, P. Serruys, S. Windecker, 2010 .

P. Serruys, H. Garcia-Garcia, B. Chevalier, 2012, American heart journal.

6-month clinical outcomes following implantation of the bioresorbable everolimus-eluting vascular scaffold in vessels smaller or larger than 2.5 mm.

R. Whitbourn, P. Serruys, S. Windecker, 2011, Journal of the American College of Cardiology.